Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7453)
All Articles published online
|
Publishing Process of This Article
|
Jun 21, 2014 (publication date) through Oct 22, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Kang W, Park JY. When to stop nucleos(t)ide analogues treatment for chronic hepatitis B? Durability of antiviral response. World J Gastroenterol 2014; 20(23): 7207-7212 [PMID: 24966590 DOI: 10.3748/wjg.v20.i23.7207] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Kang W, Park JY. When to stop nucleos(t)ide analogues treatment for chronic hepatitis B? Durability of antiviral response. World J Gastroenterol 2014; 20(23): 7207-7212 [PMID: 24966590 DOI: 10.3748/wjg.v20.i23.7207] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i23/7207.htm |
| Number | Citing Articles |
| 1 |
Mi Na Kim, Jun Yong Park, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Kwang‐Hyub Han. Durability of the virological response after lamivudine discontinuation in lamivudine‐resistant patients with a complete virological response after lamivudine and adefovir combination therapy. Journal of Medical Virology 2017; 89(1): 85 doi: 10.1002/jmv.24616
|
| 2 |
Bryan R. Cobb, Alexandra Valsamakis, Randall T. Hayden, Donna M. Wolk, Karen C. Carroll, Yi-Wei Tang. Chronic Hepatitis B, C, and D. Microbiology Spectrum 2016; 4(4) doi: 10.1128/microbiolspec.DMIH2-0025-2015
|
| 3 |
Lei Duan, Yang Liu, Dingyu Wu, Ting Wen, Song Huang, Xiuyun Zhu, Guangyan Sun, Guohong Yang, Yinbao Hu, Shoucui Pu, Qiangwei Zeng, Qingyu Yang. Global trends and insights in interferon therapy for chronic hepatitis B: a bibliometric analysis. Virology Journal 2025; 22(1) doi: 10.1186/s12985-025-02922-4
|
| 4 |
Naruhiko Nagata, Tatehiro Kagawa, Shunji Hirose, Yoshitaka Arase, Kota Tsuruya, Kazuya Anzai, Koichi Shiraishi, Tetsuya Mine. Off-treatment durability of antiviral response to nucleoside analogues in patients with chronic hepatitis B. BMC Gastroenterology 2016; 16(1) doi: 10.1186/s12876-016-0454-z
|
| 5 |
Li Gao, Yue Hu, Xiaofeng Shi, Xin Li, Dazhi Zhang, Hong Ren. 48 weeks outcome after cessation of nucleos(t)ide analogue therapy in chronic hepatitis B patients. Annals of Hepatology 2020; 19(3): 329 doi: 10.1016/j.aohep.2019.10.006
|
| 6 |
Kyu Sik Jung, Jun Yong Park, Young Eun Chon, Hyon-Suk Kim, Wonseok Kang, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Kwang-Hyub Han, Sang Hoon Ahn. Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients. Journal of Gastroenterology 2016; 51(8): 830 doi: 10.1007/s00535-015-1153-1
|
| 7 |
Hideyuki Tamai, Yoshiyuki Ida, Naoki Shingaki, Ryo Shimizu, Kazuhiro Fukatsu, Masahiro Itonaga, Takeichi Yoshida, Yoshimasa Maeda, Kosaku Moribata, Takao Maekita, Mikitaka Iguchi, Jun Kato, Masayuki Kitano. Add-on Pegylated Interferon Alpha-2a Therapy in Chronic Hepatitis B Japanese Patients Treated with Entecavir. Hepatitis Research and Treatment 2017; 2017: 1 doi: 10.1155/2017/2093847
|
| 8 |
Bryan R. Cobb, Alexandra Valsamakis. Diagnostic Microbiology of the Immunocompromised Host. 2016; : 69 doi: 10.1128/9781555819040.ch3
|